ID

39148

Descrizione

Study ID: 108062 Clinical Study ID: 108062 Study Title: A three part, staggered cohort, open-label and double blind, randomized, placebo controlled study to investigate the efficacy, safety, tolerability and pharmacokinetics of eltrombopag, a thrombopoietin receptor agonist, in previously treated pediatric patients with chronic idiopathic thrombocytopenic purpura (ITP). Eltrombopag PETIT: Eltrombopag in PEdiatric patients with Thrombocytopenia from ITP Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00908037 https://clinicaltrials.gov/ct2/show/NCT00908037 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: eltrombopag, Placebo Trade Name: N/A Study Indication: Purpura, Thrombocytopaenic, Idiopathic The study consists of a screening, Day 1 and three parts. All subjects were supposed to receive 24 weeks (6 months) of eltrombopag treatment during Part 2/3. Screening period: Up to 28 days prior to Day 1 of treatment. Day 1 Part 1 (Dose Finding Phase): A 24-week (6 months) open label treatment period for 5 subjects in each age cohort. (short: P1W1-P1W7, P1W8-23, P1W24/EW). A safety, PK and platelet count review took place after 12 weeks (3 months) of treatment. Subjects in the Dose Finding Phase did not participate in the Randomized Period. Part 2 (Randomized Period): A 7-week randomized, double-blind, placebo-controlled period involving 18 subjects per cohort (short: P2W1-P2W7). Part 3: An open-label treatment period where subjects randomized to eltrombopag in Part 2 received an additional 17 weeks of eltrombopag in Part 3 and subjects randomized to placebo in Part 2 received 24 weeks of eltrombopag in Part 3 (short: P3W8-P3W23, P3W24/EW, P3W8-30, P3W31/EW). Follow-up: 4 weeks following the last dose of eltrombopag (short: FUW1- FUW4). Additional ocular examinations were performed at 12 and 24 weeks (3 and 6 months) after the last dose of eltrombopag (short: FUM3, FUM6). The subjects were enrolled in 3 cohorts: Cohort 1: Subjects between 12 and 17 years old (<18 years of age at Day 1). Cohort 2: Subjects between 6 and 11 years old (<12 years of age at Day 1). Cohort 3: Subjects between 1 and 5 years old (<6 years of age at Day 1). The enrollment was started with the oldest cohort (Cohort 1). The younger cohorts were not enrolled until safety, PK and platelet counts had been reviewed in the older cohort(s). This document contains the liver events form. It has to be filled in if a liver event occurs during study.

collegamento

https://clinicaltrials.gov/ct2/show/NCT00908037

Keywords

versioni (2)
  1. 24/10/19 24/10/19 -
  2. 05/12/19 05/12/19 - Sarah Riepenhausen
Titolare del copyright

GlaxoSmithKline

Caricato su

5 dicembre 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Effects of eltrombopag in children with chronic idiopathic thrombocytopenic purpura, NCT00908037

Inglese

Liver events

1 moduli  
  1. StudyEvent: ODM
    1. Liver events
Administrative data
Descrizione

Administrative data

Alias
UMLS CUI-1
C1320722
Subject number
Descrizione

Subject number

Tipo di dati

text

Alias
UMLS CUI [1]
C2348585
General Information
Descrizione

General Information

Alias
UMLS CUI-1
C1508263
Notification Sent [read-only]
Descrizione

Item is not required. Please note the date and time of each you've ticked.

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0422202
UMLS CUI [1,2]
C0023884
Date of notification
Descrizione

day month year

Tipo di dati

date

Alias
UMLS CUI [1]
C1302584
Time of notification
Descrizione

00:00-23:59

Tipo di dati

time

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C0422202
Liver event
Descrizione

Liver event

Alias
UMLS CUI-1
C0023884
UMLS CUI-2
C0877248
Is this liver event a serious adverse event?
Descrizione

If you tick yes, please complete liver event forms and serious adverse event form immediately.

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1710056
UMLS CUI [1,2]
C0023884
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping/interruption criteria? ALT (alanine aminotransferase)
Descrizione

alanine aminotransferase stop criterion

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0151905
UMLS CUI [1,2]
C2746065
UMLS CUI [1,3]
C0243161
AST (aspartate aminotransferase)
Descrizione

Which liver chemistry result reached or exceeded protocol-defined investigational product stopping/interruption criteria?

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0201899
UMLS CUI [1,2]
C2746065
UMLS CUI [1,3]
C0243161
Total bilirubin
Descrizione

Which liver chemistry result reached or exceeded protocol-defined investigational product stopping/interruption criteria?

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0201913
UMLS CUI [1,2]
C2746065
UMLS CUI [1,3]
C0243161
Alkaline phosphatase
Descrizione

Which liver chemistry result reached or exceeded protocol-defined investigational product stopping/interruption criteria?

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0201850
UMLS CUI [1,2]
C2746065
UMLS CUI [1,3]
C0243161
5' nucleotidase
Descrizione

Which liver chemistry result reached or exceeded protocol-defined investigational product stopping/interruption criteria? This item is conditional. Interruption may be removed if stopping/monitoring study only.

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2700357
UMLS CUI [1,2]
C2746065
UMLS CUI [1,3]
C0243161
Gammaglutamyltranspeptidase
Descrizione

Which liver chemistry result reached or exceeded protocol-defined investigational product stopping/interruption criteria? This item is conditional. Interruption may be removed if stopping/monitoring study only.

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0541979
UMLS CUI [1,2]
C2746065
UMLS CUI [1,3]
C0243161
Other
Descrizione

Which liver chemistry result reached or exceeded protocol-defined investigational product stopping/interruption criteria?

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C2746065
UMLS CUI [1,3]
C0243161
Is the subject age 55 or older?
Descrizione

Age

Tipo di dati

text

Alias
UMLS CUI [1]
C0001779
If female, Is the subject pregnant?
Descrizione

If you tick yes, ensure Pregnancy Notification Form has been completed.

Tipo di dati

text

Alias
UMLS CUI [1]
C0032961
Were any diagnostic Imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance Imaging or MRI, or endoscopic retrograde cholanglopancreatography, or other)?
Descrizione

If you tick yes, please note the results of test in the following item.

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0011923
UMLS CUI [1,2]
C0023884
UMLS CUI [1,3]
C1711359
UMLS CUI [2,1]
C0041618
UMLS CUI [2,2]
C0023884
UMLS CUI [3]
C1275400
UMLS CUI [4]
C0024485
UMLS CUI [5]
C0008310
If diagnostic imaging tests were performed, were the results normal?
Descrizione

If no, record the details on the Imaging form. Please ensure the overall diagnosis Indicated by Imaging Is captured on the Non-serious Adverse Event form or Serious Adverse Event form.

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1274040
UMLS CUI [1,2]
C0011923
were any liver biopsies performed?
Descrizione

If you tick yes, complete Liver Biopsy form.

Tipo di dati

text

Alias
UMLS CUI [1]
C0193388
Does the subject use herbals, complementary or altemative medicines, food supplements (vitamins) or illicit drugs?
Descrizione

If you tick yes, record on the appropriate Concomitant Medication form.

Tipo di dati

text

Alias
UMLS CUI [1]
C2240391
UMLS CUI [2,1]
C1148474
UMLS CUI [2,2]
C0002346
UMLS CUI [3]
C0242295
UMLS CUI [4]
C0086190
Did the subject fast or undergo significant dietary change In the past week?
Descrizione

Fast or significant dietary change

Tipo di dati

text

Alias
UMLS CUI [1]
C0015663
UMLS CUI [2]
C3671772
Evaluation interval code [hidden]
Descrizione

Evaluation interval code

Tipo di dati

text

Alias
UMLS CUI [1]
C2985767
Investigational product (Liver)
Descrizione

Investigational product (Liver)

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0023884
When did the liver event occur?
Descrizione

Onset of liver event

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2985916
UMLS CUI [1,2]
C0023884
Start Date investigational Product
Descrizione

day month year. If the liver event occurred during/after treatment period record start date of lnvestigatlonal product for that treatment period.

Tipo di dati

partialDate

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0808070
Start date not applicable
Descrizione

investigational product Start date not applicable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C1272460
End Date investigational Product
Descrizione

day month year. If the liver event occurred during/after treatment period record end date of lnvestigatlonal product for that treatment period.

Tipo di dati

partialDate

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0806020
End date not applicable
Descrizione

investigational product end date not applicable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C1272460
Pharmacokinetics (Liver PK)
Descrizione

Pharmacokinetics (Liver PK)

Alias
UMLS CUI-1
C0031328
Was a pharmacokinetic blood sample obtained?
Descrizione

Design notes: An unscheduled PK sample must be obtained within 72 hours of last dose

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0178913
If a pharmacokinetic blood sample was taken note the Date
Descrizione

day month year

Tipo di dati

date

Alias
UMLS CUI [1,1]
C1302413
UMLS CUI [1,2]
C0031328
If a pharmacokinetic blood sample was taken note the time
Descrizione

00:00-23:59

Tipo di dati

time

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C0200345
UMLS CUI [1,3]
C0031328
If a pharmacokinetic blood sample was taken note the Date of last investigational product dose prior to PK sample
Descrizione

day month year

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1762893
If a pharmacokinetic blood sample was taken note the time of last investigational product dose prior to PK sample
Descrizione

00:00-23:59

Tipo di dati

time

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0946444
Sample Identifier/Sample Number
Descrizione

Sample Identifier/Sample Number Pharmacokinetics

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1299222
UMLS CUI [1,2]
C0031328
Liver disease medical conditions
Descrizione

Liver disease medical conditions

Alias
UMLS CUI-1
C0023895
UMLS CUI-2
C0262926
Specific Condition
Descrizione

Specific Condition

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C2348235
Presence of disease
Descrizione

Tick only one response for each condition

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C3854307
UMLS CUI [1,2]
C0012634
Drug related liver disease condition (All drugs including lnvestigational Product)
Descrizione

Drug related liver disease condition (All drugs including lnvestigational Product)

Alias
UMLS CUI-1
C0023895
UMLS CUI-2
C0277579
Drug related liver disease
Descrizione

Drug related liver disease

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0277579
Other liver disease conditions
Descrizione

Other liver disease conditions

Alias
UMLS CUI-1
C0023895
UMLS CUI-2
C0205394
Sequence Number [hidden]
Descrizione

Item is not required

Tipo di dati

integer

Alias
UMLS CUI [1]
C2348184
Specific condition
Descrizione

Specific condition

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C2348235
Modified Term [hidden]
Descrizione

Item is not required

Tipo di dati

text

Alias
UMLS CUI [1]
C2826302
MeDRA Synonym [hidden]
Descrizione

Item is not required

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1140263
UMLS CUI [1,2]
C0871468
MedDRA lower level term code [hidden]
Descrizione

Item is not required

Tipo di dati

text

Alias
UMLS CUI [1]
C3898442
Failed coding [hidden]
Descrizione

Item is not required

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0805701
UMLS CUI [1,2]
C0231175
Status
Descrizione

This item is optional

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0449438
UMLS CUI [1,2]
C0023895
UMLS CUI [1,3]
C0205394
Other medical conditions
Descrizione

Other medical conditions

Alias
UMLS CUI-1
C0012634
UMLS CUI-2
C0205394
Disease
Descrizione

Disease

Tipo di dati

integer

Alias
UMLS CUI [1]
C0012634
Presence of disease
Descrizione

Presence of disease

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C3854307
UMLS CUI [1,2]
C0012634
Alcohol intake at onset of liver event (Liver alcohol)
Descrizione

Alcohol intake at onset of liver event (Liver alcohol)

Alias
UMLS CUI-1
C0001948
UMLS CUI-2
C0023884
UMLS CUI-3
C0332162
UMLS CUI-4
C0877248
Does the subject consume alcohol?
Descrizione

Consumption of alcohol

Tipo di dati

text

Alias
UMLS CUI [1]
C0001948
If alcohol consumption, record the average number of units of alcohol consumed per week
Descrizione

For the SUALUNWK textbox the 2 decimal point section is optional. Study teams are allowed to capture whole numbers if required. This item will be calculated by Inform.

Tipo di dati

float

Unità di misura
  • units per week
Alias
UMLS CUI [1,1]
C0001948
UMLS CUI [1,2]
C0560579
units per week
Substance use type [hidden]
Descrizione

This item will be calculated by Inform.

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0038586
UMLS CUI [1,2]
C0332307
Ritorna all'inizio della pagina

Similar models

Liver events

1 moduli
  1. StudyEvent: ODM
    1. Liver events
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Administrative data
C1320722 (UMLS CUI-1)
Subject number
Item
Subject number
text
C2348585 (UMLS CUI [1])
Item Group
General Information
C1508263 (UMLS CUI-1)
Item
Notification Sent [read-only]
integer
C0422202 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
Notification Sent
Code List
Notification Sent [read-only]
CL Item
Last Email Sent to Medical Monitor (1)
CL Item
Initial Email Sent to Medical Monitor (2)
CL Item
Last Email Sent to GCSP (3)
CL Item
lnitial Email Sent to GCSP (4)
CL Item
Changed to Non Serious (5)
Date of notification
Item
Date of notification
date
C1302584 (UMLS CUI [1])
Time of notification
Item
Time of notification
time
C0040223 (UMLS CUI [1,1])
C0422202 (UMLS CUI [1,2])
Item Group
Liver event
C0023884 (UMLS CUI-1)
C0877248 (UMLS CUI-2)
Item
Is this liver event a serious adverse event?
text
C1710056 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
Seriousness of liver event
Code List
Is this liver event a serious adverse event?
CL Item
Yes (Y)
CL Item
No (N)
alanine aminotransferase stop criterion
Item
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping/interruption criteria? ALT (alanine aminotransferase)
boolean
C0151905 (UMLS CUI [1,1])
C2746065 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
aspartate aminotransferase stop criterion
Item
AST (aspartate aminotransferase)
boolean
C0201899 (UMLS CUI [1,1])
C2746065 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
Total bilirubin stop criterion
Item
Total bilirubin
boolean
C0201913 (UMLS CUI [1,1])
C2746065 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
Alkaline phosphatase stop criterion
Item
Alkaline phosphatase
boolean
C0201850 (UMLS CUI [1,1])
C2746065 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
5' nucleotidase stop criterion
Item
5' nucleotidase
boolean
C2700357 (UMLS CUI [1,1])
C2746065 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
Gammaglutamyltranspeptidase stop criterion
Item
Gammaglutamyltranspeptidase
boolean
C0541979 (UMLS CUI [1,1])
C2746065 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
Other stop criterion
Item
Other
boolean
C0205394 (UMLS CUI [1,1])
C2746065 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
Item
Is the subject age 55 or older?
text
C0001779 (UMLS CUI [1])
Age
Code List
Is the subject age 55 or older?
CL Item
Yes (Y)
CL Item
No (N)
Item
If female, Is the subject pregnant?
text
C0032961 (UMLS CUI [1])
Pregnancy
Code List
If female, Is the subject pregnant?
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Not applicable (X)
Item
Were any diagnostic Imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance Imaging or MRI, or endoscopic retrograde cholanglopancreatography, or other)?
text
C0011923 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
C1711359 (UMLS CUI [1,3])
C0041618 (UMLS CUI [2,1])
C0023884 (UMLS CUI [2,2])
C1275400 (UMLS CUI [3])
C0024485 (UMLS CUI [4])
C0008310 (UMLS CUI [5])
Diagnostic Imaging tests of the liver or hepatobiliary system
Code List
Were any diagnostic Imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance Imaging or MRI, or endoscopic retrograde cholanglopancreatography, or other)?
CL Item
Yes (Y)
CL Item
No (N)
Item
If diagnostic imaging tests were performed, were the results normal?
text
C1274040 (UMLS CUI [1,1])
C0011923 (UMLS CUI [1,2])
Result of diagnostic imaging tests
Code List
If diagnostic imaging tests were performed, were the results normal?
CL Item
Yes (Y)
CL Item
No (N)
Item
were any liver biopsies performed?
text
C0193388 (UMLS CUI [1])
Liver biopsies
Code List
were any liver biopsies performed?
CL Item
Yes (Y)
CL Item
No (N)
Item
Does the subject use herbals, complementary or altemative medicines, food supplements (vitamins) or illicit drugs?
text
C2240391 (UMLS CUI [1])
C1148474 (UMLS CUI [2,1])
C0002346 (UMLS CUI [2,2])
C0242295 (UMLS CUI [3])
C0086190 (UMLS CUI [4])
Use of herbals, complementary or altemative medicines, food supplements, illicit drugs
Code List
Does the subject use herbals, complementary or altemative medicines, food supplements (vitamins) or illicit drugs?
CL Item
Yes (Y)
CL Item
No (N)
Item
Did the subject fast or undergo significant dietary change In the past week?
text
C0015663 (UMLS CUI [1])
C3671772 (UMLS CUI [2])
Fast or significant dietary change
Code List
Did the subject fast or undergo significant dietary change In the past week?
CL Item
Yes (Y)
CL Item
No (N)
Evaluation interval code
Item
Evaluation interval code [hidden]
text
C2985767 (UMLS CUI [1])
Item Group
Investigational product (Liver)
C0304229 (UMLS CUI-1)
C0023884 (UMLS CUI-2)
Item
When did the liver event occur?
text
C2985916 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
Onset of liver event
Code List
When did the liver event occur?
CL Item
During the treatment period (D)
CL Item
After the treatment period (A)
Start Date investigational Product
Item
Start Date investigational Product
partialDate
C0304229 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
investigational product Start date not applicable
Item
Start date not applicable
boolean
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])
End Date investigational Product
Item
End Date investigational Product
partialDate
C0304229 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
investigational product end date not applicable
Item
End date not applicable
boolean
C0806020 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])
Item Group
Pharmacokinetics (Liver PK)
C0031328 (UMLS CUI-1)
Item
Was a pharmacokinetic blood sample obtained?
text
C0031328 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
Pharmacokinetic blood sample
Code List
Was a pharmacokinetic blood sample obtained?
CL Item
Yes (Y)
CL Item
No (N)
Date sample taken
Item
If a pharmacokinetic blood sample was taken note the Date
date
C1302413 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
Time sample taken
Item
If a pharmacokinetic blood sample was taken note the time
time
C0040223 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0031328 (UMLS CUI [1,3])
Date of last investigational product dose
Item
If a pharmacokinetic blood sample was taken note the Date of last investigational product dose prior to PK sample
date
C0304229 (UMLS CUI [1,1])
C1762893 (UMLS CUI [1,2])
Time of last investigational product dose
Item
If a pharmacokinetic blood sample was taken note the time of last investigational product dose prior to PK sample
time
C0304229 (UMLS CUI [1,1])
C0946444 (UMLS CUI [1,2])
Sample Identifier/Sample Number Pharmacokinetics
Item
Sample Identifier/Sample Number
text
C1299222 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
Item Group
Liver disease medical conditions
C0023895 (UMLS CUI-1)
C0262926 (UMLS CUI-2)
Item
Specific Condition
integer
C0012634 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Specific Condition
Code List
Specific Condition
CL Item
Acute Viral Hepatitis A (1)
CL Item
Chronic Hepatitis B (2)
CL Item
Chronic Hepatitis C (3)
CL Item
Cytomegalovirus Hepatitis (4)
CL Item
Epstein Barr Virus Infectious Mononucleosis (5)
CL Item
Herpes Simplex Hepatitis (6)
CL Item
Alcoholic Liver Disease (7)
CL Item
Non-alcoholic Steatohepatitis (8)
CL Item
Fatty Liver (9)
CL Item
Hepatic Cirrhosis (10)
CL Item
Hemochromatosis (11)
CL Item
Autoimmune Hepatitis (12)
CL Item
Gallbladder disease (13)
Item
Presence of disease
integer
C3854307 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
Presence of disease
Code List
Presence of disease
CL Item
Current (1)
CL Item
Past (2)
CL Item
No Medical Condition (5)
Item Group
Drug related liver disease condition (All drugs including lnvestigational Product)
C0023895 (UMLS CUI-1)
C0277579 (UMLS CUI-2)
Item
Drug related liver disease
integer
C0023895 (UMLS CUI [1,1])
C0277579 (UMLS CUI [1,2])
Drug related liver disease
Code List
Drug related liver disease
CL Item
Current (1)
CL Item
Past (2)
CL Item
No Medical Condition (3)
Item Group
Other liver disease conditions
C0023895 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
Sequence Number
Item
Sequence Number [hidden]
integer
C2348184 (UMLS CUI [1])
Specific condition
Item
Specific condition
text
C0023895 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Modified Term
Item
Modified Term [hidden]
text
C2826302 (UMLS CUI [1])
MeDRA Synonym
Item
MeDRA Synonym [hidden]
text
C1140263 (UMLS CUI [1,1])
C0871468 (UMLS CUI [1,2])
MedDRA lower level term code
Item
MedDRA lower level term code [hidden]
text
C3898442 (UMLS CUI [1])
Failed coding
Item
Failed coding [hidden]
text
C0805701 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
Item
Status
integer
C0449438 (UMLS CUI [1,1])
C0023895 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Status
Code List
Status
CL Item
Current (1)
CL Item
Past (2)
Item Group
Other medical conditions
C0012634 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
Item
Disease
integer
C0012634 (UMLS CUI [1])
Disease
Code List
Disease
CL Item
Drug Allergies (1)
CL Item
Rheumatoid Arthritis (2)
CL Item
Psoriasis (3)
CL Item
Thyroid Disease (4)
CL Item
Inflammatory Bowel Disease (5)
CL Item
Lupus (6)
CL Item
Sjogren's Syndrome (7)
CL Item
Vitiligo (8)
Item
Presence of disease
integer
C3854307 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
Presence of disease
Code List
Presence of disease
CL Item
Current (1)
(Comment:en)
CL Item
Past (2)
(Comment:en)
CL Item
No Medical Condition (5)
(Comment:en)
Item Group
Alcohol intake at onset of liver event (Liver alcohol)
C0001948 (UMLS CUI-1)
C0023884 (UMLS CUI-2)
C0332162 (UMLS CUI-3)
C0877248 (UMLS CUI-4)
Item
Does the subject consume alcohol?
text
C0001948 (UMLS CUI [1])
Consumption of alcohol
Code List
Does the subject consume alcohol?
CL Item
No (N)
CL Item
Yes (Y)
Alcohol consumption per week
Item
If alcohol consumption, record the average number of units of alcohol consumed per week
float
C0001948 (UMLS CUI [1,1])
C0560579 (UMLS CUI [1,2])
Substance use type
Item
Substance use type [hidden]
text
C0038586 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial